A Study to Evaluate Vonoprazan in Children Who Have Symptomatic Gastroesophageal Reflux Disease
Public ClinicalTrials.gov record NCT06106022. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1, Randomized, Parallel-group, Open-label, Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Vonoprazan (10 or 20 mg Once Daily) in Children Aged ≥ 6 to < 12 Years Who Have Symptomatic Gastroesophageal Reflux Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The aim of this study is to evaluate the pharmacokinetic (PK) profile of vonoprazan (10 or 20 mg once daily \[QD\]) in children ≥ 6 to \< 12 years of age who have symptomatic Gastroesophageal Reflux Disease (GERD).
Study identification
- NCT ID
- NCT06106022
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 22 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 6 Years to 11 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 1, 2023 (Actual)
- Primary completion
- Apr 16, 2024 (Actual)
- Completion
- Apr 29, 2024 (Actual)
- Last update posted
- Dec 19, 2024
2023 – 2024
United States locations
- U.S. sites
- 13
- U.S. states
- 10
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Strada Patient Care Center | Mobile | Alabama | 36604 | — |
| Preferred Research Partners, Inc. | Little Rock | Arkansas | 72211 | — |
| Med Research Associates, Inc | Hollywood | Florida | 33024 | — |
| Avanza Medical Research Center | Pensacola | Florida | 32503 | — |
| International Center for Research | Tampa | Florida | 33614 | — |
| Children's Center for Digestive Health Care, LLC | Atlanta | Georgia | 30342 | — |
| Riley Hospital for Children at IU Health | Indianapolis | Indiana | 46202 | — |
| Tandem Clinical Research GI, LLC | Marrero | Louisiana | 70072 | — |
| Advantage Clinical Trials | The Bronx | New York | 10467 | — |
| PriMED Clinical Research | Dayton | Ohio | 45429 | — |
| Cyn3rgy Research | Gresham | Oregon | 97030 | — |
| Maspons Pediatric Gastro | El Paso | Texas | 79902 | — |
| Stryde Research - NxT Step Pediatrics | Frisco | Texas | 75033 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06106022, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 19, 2024 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06106022 live on ClinicalTrials.gov.